Related Experiment Video

Updated: Sep 29, 2025

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.0K

Ferroptosis Related Genes in Ischemic and Idiopathic Cardiomyopathy: Screening for Potential Pharmacological Targets

Yufeng Jiang1, Ling Chen2, Zhujun Chao3

  • 1Department of Cardiology, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou, China.

Frontiers in Cell and Developmental Biology
|March 21, 2022
PubMed

Insights

Ferroptosis, a novel cell death form, shows potential in treating cardiomyopathy. This study identifies key ferroptosis genes and drugs for precision medicine in ischemic and idiopathic cardiomyopathy.

Area of Science:

  • Biomedical research
  • Genomics
  • Cardiovascular disease

Background:

  • Ferroptosis is a newly identified cell death mechanism distinct from apoptosis, necrosis, and autophagy.
  • Understanding ferroptosis pathways is crucial for developing novel therapeutic strategies for various diseases.
  • Cardiomyopathy, a significant cause of heart failure, presents an unmet need for innovative treatment approaches.

Purpose of the Study:

  • To investigate the role of ferroptosis-related genes in the pathogenesis of ischemic and idiopathic cardiomyopathy.
  • To identify potential therapeutic targets and drug candidates for cardiomyopathy treatment through bioinformatics analysis.
  • To explore ferroptosis as a novel therapeutic avenue for managing heart muscle diseases.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) database (GSE5406) for differential expression analysis via GEO2R.
  • Performed functional annotation of ferroptosis-related genes and constructed protein-protein interaction networks using Cytoscape.
  • Screened potential drug targets by analyzing hub genes with the Connectivity Map (cMap) database.

Main Results:

  • Identified 15 ferroptosis-related genes (4 upregulated, 11 downregulated) in ischemic cardiomyopathy and 17 genes (13 upregulated, 4 downregulated) in idiopathic cardiomyopathy.
  • Functional analysis revealed involvement in apoptosis regulation, metabolic processes, and drug response, with key pathways including MAPK and PI3K-Akt signaling.
  • Generated co-expression networks for hub genes and proposed top drug candidates for both cardiomyopathy types.

Conclusions:

  • Bioinformatics analysis highlights the significant role of ferroptosis-related genes in ischemic and idiopathic cardiomyopathy.
  • Identified hub genes and potential therapeutic drugs may serve as novel biomarkers for prognosis and precision treatment.
  • Ferroptosis presents a promising new direction for future cardiomyopathy therapies.
Keywords:
cardiomyopathyferroptosisidiopathicischemicprecision medicine

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.7K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
76
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
64
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
94
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46